Cell-cycle regulation of DNA damage-induced expression of the suppressor gene PML
- PMID: 9398618
- DOI: 10.1006/bbrc.1997.7692
Cell-cycle regulation of DNA damage-induced expression of the suppressor gene PML
Abstract
The promyelocytic leukemia (PML) gene, which encodes a growth- and transformation-suppressor, has been identified at the non-random chromosomal translocation break point t(15; 17)(q22; q12) of acute promyelocytic leukemia. To elucidate if PML may play a role in cellular response to DNA damage, PML expression was analyzed by immunofluorescence staining in HeLa cells treated with ionizing radiation (IR) and cisplatin. Our studies demonstrated IR at 20Gy, and cisplatin at 6 micrograms/ml caused more than 5-10 fold increases in PML protein expression in the PML Oncogenic Domain (POD) by immunofluorescent staining. Northern blotting showed that there was no gross increase in mRNA levels indicating that the induction is a post-transcriptional event. Flow cytometry showed that HeLa cells treated with IR were progressively arrested in G1, which correlates with the optimal expression of PML in the cell cycle. To determine if PML expression was under the control of the tumor suppressor p53, which is known to arrest cells in G1, HeLa cells were transfected with the wild-type p53 gene. PML expression in p53 transduced cells were 5-10 fold higher than the control, indicating that the enhanced expression of PML is apparently dependent on the p53 pathway. These data also indicate that PML may play an important role in cellular response to DNA damage such as DNA repair or apoptosis during G1 arrest.
Similar articles
-
The function of PML in p53-dependent apoptosis.Nat Cell Biol. 2000 Oct;2(10):730-6. doi: 10.1038/35036365. Nat Cell Biol. 2000. PMID: 11025664
-
AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.Oncogene. 2011 Mar 10;30(10):1194-204. doi: 10.1038/onc.2010.499. Epub 2010 Nov 8. Oncogene. 2011. PMID: 21057547
-
Evidence for the receipt of DNA damage stimuli by PML nuclear domains.J Pathol. 2007 Mar;211(4):471-80. doi: 10.1002/path.2126. J Pathol. 2007. PMID: 17206596
-
The puzzling multiple lives of PML and its role in the genesis of cancer.Bioessays. 2000 Sep;22(9):827-35. doi: 10.1002/1521-1878(200009)22:9<827::AID-BIES8>3.0.CO;2-1. Bioessays. 2000. PMID: 10944585 Review.
-
Acute promyelocytic leukemia: from clinic to molecular biology.Stem Cells. 1995 Jan;13(1):22-31. doi: 10.1002/stem.5530130104. Stem Cells. 1995. PMID: 7719245 Review.
Cited by
-
Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.PLoS Pathog. 2008 Oct 3;4(10):e1000170. doi: 10.1371/journal.ppat.1000170. PLoS Pathog. 2008. PMID: 18833293 Free PMC article.
-
The tumor suppressor PML specifically accumulates at RPA/Rad51-containing DNA damage repair foci but is nonessential for DNA damage-induced fibroblast senescence.Mol Cell Biol. 2014 May;34(10):1733-46. doi: 10.1128/MCB.01345-13. Epub 2014 Mar 10. Mol Cell Biol. 2014. PMID: 24615016 Free PMC article.
-
PML: An emerging tumor suppressor and a target with therapeutic potential.Cancer Ther. 2009 Sep 1;7(A):219-226. Cancer Ther. 2009. PMID: 19756257 Free PMC article.
-
Altered expression of the suppressors PML and p53 in glioblastoma cells with the antisense-EGF-receptor.Br J Cancer. 1999 Nov;81(6):994-1001. doi: 10.1038/sj.bjc.6690798. Br J Cancer. 1999. PMID: 10576656 Free PMC article.
-
Dysregulation of promyelocytic leukemia (PML) protein expression in preeclamptic placentae.Reprod Sci. 2010 Apr;17(4):339-49. doi: 10.1177/1933719109358455. Reprod Sci. 2010. PMID: 20228380 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous